Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Flexion Therapeutics stock

Own Flexion Therapeutics stock in just a few minutes.

Flexion Therapeutics, Inc is a drug manufacturers-specialty & generic business based in the US. Flexion Therapeutics shares (FLXN) are listed on the NASDAQ and all prices are listed in US Dollars. Flexion Therapeutics employs 257 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Flexion Therapeutics

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – FLXN – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Flexion Therapeutics share price

Use our graph to track the performance of FLXN stocks over time.

Flexion Therapeutics shares at a glance

Information last updated 2021-04-30.
52-week range$7.80 - $14.39
50-day moving average $9.33
200-day moving average $11.20
Wall St. target price$19.77
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-4.28

Buy Flexion Therapeutics shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
A free way to invest in stocks, ETFs and crypto.
Robinhood
$0
Stocks, Options, ETFs
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Interactive Brokers
$0
Stocks, Bonds, Options, Mutual funds, ETFs, Currencies
$0 + $0.65/contract, $1 minimum
0%
N/A
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Webull
$0
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $2.50 and $250 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Public
$0
Stocks, ETFs
N/A
$0 per month
N/A
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Flexion Therapeutics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Flexion Therapeutics financials

Revenue TTM $85.6 million
Gross profit TTM $66.5 million
Return on assets TTM -24.77%
Return on equity TTM -6256.74%
Profit margin -132.91%
Book value $0.34
Market capitalisation $404.4 million

TTM: trailing 12 months

Shorting Flexion Therapeutics shares

There are currently 7.3 million Flexion Therapeutics shares held short by investors – that's known as Flexion Therapeutics's "short interest". This figure is 8.7% down from 8.0 million last month.

There are a few different ways that this level of interest in shorting Flexion Therapeutics shares can be evaluated.

Flexion Therapeutics's "short interest ratio" (SIR)

Flexion Therapeutics's "short interest ratio" (SIR) is the quantity of Flexion Therapeutics shares currently shorted divided by the average quantity of Flexion Therapeutics shares traded daily (recently around 1.3 million). Flexion Therapeutics's SIR currently stands at 5.7. In other words for every 100,000 Flexion Therapeutics shares traded daily on the market, roughly 5700 shares are currently held short.

However Flexion Therapeutics's short interest can also be evaluated against the total number of Flexion Therapeutics shares, or, against the total number of tradable Flexion Therapeutics shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Flexion Therapeutics's short interest could be expressed as 0.15% of the outstanding shares (for every 100,000 Flexion Therapeutics shares in existence, roughly 150 shares are currently held short) or 0.1979% of the tradable shares (for every 100,000 tradable Flexion Therapeutics shares, roughly 198 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Flexion Therapeutics.

Find out more about how you can short Flexion Therapeutics stock.

Flexion Therapeutics share dividends

We're not expecting Flexion Therapeutics to pay a dividend over the next 12 months.

Flexion Therapeutics share price volatility

Over the last 12 months, Flexion Therapeutics's shares have ranged in value from as little as $7.8 up to $14.39. A popular way to gauge a stock's volatility is its "beta".

FLXN.US volatility(beta: 1.48)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Flexion Therapeutics's is 1.4815. This would suggest that Flexion Therapeutics's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Flexion Therapeutics overview

Flexion Therapeutics, Inc. , a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for the treatment of patients with musculoskeletal conditions in the United States. The company offers ZILRETTA, an intra-articular injection for the management of osteoarthritis (OA) knee pain. It is also involved in the development of FX201, a gene therapy product candidate designed to provide on demand production of an anti-inflammatory protein, interleukin-1 receptor antagonist for pain relief from OA of the knee; and FX301, a NaV1. 7 inhibitor for the management of post-operative pain. The company was founded in 2007 and is headquartered in Burlington, Massachusetts. .

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site